| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3771052
Max Phase: Preclinical
Molecular Formula: C32H41F2N7O2
Molecular Weight: 593.72
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1cc(C[C@@H](NC(=O)N2CCN(c3ccc(F)c(F)c3)CC2)C(=O)N2CCC(N3CCCCC3)CC2)cc2cn[nH]c12
Standard InChI: InChI=1S/C32H41F2N7O2/c1-22-17-23(18-24-21-35-37-30(22)24)19-29(31(42)40-11-7-25(8-12-40)38-9-3-2-4-10-38)36-32(43)41-15-13-39(14-16-41)26-5-6-27(33)28(34)20-26/h5-6,17-18,20-21,25,29H,2-4,7-16,19H2,1H3,(H,35,37)(H,36,43)/t29-/m1/s1
Standard InChI Key: ZBNXLAXSELTZKZ-GDLZYMKVSA-N
Associated Targets(Human)
Calcitonin gene-related peptide 1 214 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 593.72 | Molecular Weight (Monoisotopic): 593.3290 | AlogP: 4.07 | #Rotatable Bonds: 6 |
| Polar Surface Area: 87.81 | Molecular Species: BASE | HBA: 5 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 12.40 | CX Basic pKa: 9.62 | CX LogP: 3.39 | CX LogD: 1.18 |
| Aromatic Rings: 3 | Heavy Atoms: 43 | QED Weighted: 0.45 | Np Likeness Score: -1.59 |
References
| 1. Civiello RL, Han X, Beno BR, Chaturvedula PV, Herbst JJ, Xu C, Conway CM, Macor JE, Dubowchik GM.. (2016) Synthesis and SAR of calcitonin gene-related peptide (CGRP) antagonists containing substituted aryl-piperazines and piperidines., 26 (4): [PMID:26832218] [10.1016/j.bmcl.2016.01.026] |
Source
Source(1):